MAPK1 and cancer: It can also inhibit the epidermal growth factor (EGF) signaling in several cancer cell types, by preventing binding their receptor site that promotes to block the activation of activator protein-1 (AP-1) which also diminishes the transactivation activity of ERK1/ERK2 and JNK signaling protein [175].